“We know where the issues are and we have plans to fix them,” insists Bayer AG's Consumer Health head Heiko Schipper, who has been charged with implementing a wide-ranging turnaround program to return the troubled business to growth.
Speaking at the German firm’s recent capital markets day, Schipper – who took the helm at Consumer Health in March – admitted that the performance of the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?